ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Harvey I. Pass
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pass, H. I.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pass, H. I.
Related Collections
Right arrow Lung - cancer

Ann Thorac Surg 2003;76:375
© 2003 The Society of Thoracic Surgeons

Original article: general thoracic

Invited commentary

Harvey I. Pass, MDa

a Division of Cardiothoracic Surgery, Harper Hospital, Suite 2102 Harper Professional Building, 3990 John RDetroit, MI 48201, USA

e-mail: pass@cardiology.harper.wayne.edu

The first 20% of the full text of this article appears below.

Endobronchial obstruction, either from primary bronchogenic carcinoma or, as detailed by Litle represents a life-threatening mechanical problem in patients with compromised performance status. With the advent of aggressive chemotherapeutic and biologic treatment options for these patients, it is crucial to assess these patients on an individual basis and tailor treatment options in a way which is durable, complementary, and minimally toxic. Certainly, photodynamic therapy (PDT) has assumed a role in this armamentarium. Photodynamic therapy can . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.